Kari J. Remes
Turku, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data Collection.
Journal: Acta haematologica
Published: December 15, 2025
Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients.
Journal: Bone marrow transplantation
Published: April 11, 2024
Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group.
Journal: Journal of patient-reported outcomes
Published: August 10, 2023
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.
Journal: European journal of haematology
Published: June 12, 2021
A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 29, 2020
Severe neutropenia after rituximab-treatment of multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: September 19, 2017
Prophylactic platelet transfusions
Journal: Duodecim; laaketieteellinen aikakauskirja
Published: July 13, 2016
Cost analysis of a randomized stem cell mobilization study in multiple myeloma.
Journal: Annals of hematology
Published: April 26, 2016
Last Updated: 09/26/2026